Filter
293
Text search:
Parasitology
Featured
Recommendations
26
New Publications
47
Language
Document type
Studies & Reports
102
No document type
90
Guidelines
39
Manuals
27
Training Material
12
Infographics
7
Resource Platforms
5
Fact sheets
5
Strategic & Response Plan
4
Online Courses
2
Countries / Regions
Global
24
Tanzania
15
Brazil
9
Mozambique
7
Nepal
6
Latin America and the Carribbean
6
Africa
6
Uganda
5
Kenya
5
Cambodia
5
Angola
5
Myanmar / Burma
5
Senegal
4
Congo, Democratic Republic of
4
Ethiopia
4
Venezuela
4
Zambia
3
Peru
3
East and Southern Africa
3
South–East Asia Region
3
Vietnam
3
Guinea
2
Sierra Leone
2
Nigeria
2
Cameroon
2
India
2
South Sudan
2
Thailand
2
Rwanda
2
South Africa
2
Bangladesh
2
Colombia
2
Bolivia
2
Western and Central Europe
2
Paraguay
2
Asia
2
Laos
2
Burkina Faso
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Saudi Arabia
1
Ghana
1
Zimbabwe
1
Philippines
1
Pakistan
1
Iraq
1
Jordan
1
Lebanon
1
Syria
1
Chad
1
China
1
Malawi
1
Sudan
1
Argentina
1
Dominican Republic
1
North Macedonia
1
Cuba
1
Ecuador
1
Greece
1
Madagascar
1
Chile
1
West and Central Africa
1
Middle East and North Africa
1
Italy
1
Albania
1
Bulgaria
1
Iran
1
Georgia
1
Uruguay
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Countries
86
Pharmacy & Technologies
51
Clinical Guidelines
32
Public Health
16
Capacity Building
13
Key Resources
5
Women & Child Health
2
Toolboxes
NTDs
100
Malaria
41
Planetary Health
12
Rapid Response
8
HIV
7
AMR
7
Disability
5
TB
5
Ebola & Marburg
4
Mental Health
4
Pharmacy
4
Natural Hazards
3
COVID-19
3
2.0 Rapid Response
3
Zika
2
Global Health Education
2
Caregiver
2
Conflict
1
Health Financing Toolbox
1
NCDs
1
The prevalence, availability, and use of antimalarial medicines (AMLs) were studied in six Cambodian provinces along the Thai-Cambodian border. The study was divided into two parts: the first looked at the quality of AMLs available in Pursat, Pailin, Battambang, Bantey Meanchey, Oddar Meanchey, and
...
Journal of Computational Biophysics and ChemistryVol. 22, No. 01, pp. 31-41 (2023)
A global Review of evidence and practice
The internationally recognized criteria for diagnosis of neurocysticercosis include a requirement for neuroimaging techniques, such as computerized tomography (CT) and/or magnetic resonance imaging (MRI), ideally supported by serology. These facilities are not available in all settings, especially i
...
International Journal of Infectious Diseases 70 (2018) 121–130
https://doi.org/10.1016/j.ijid.2018.03.007
1201-9712/© 2018 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license (http://cr
...
This Training module on malaria elimination has been developed by WHO to support health professionals in planning, managing, monitoring and evaluating malaria elimination programmes.
Supporting exercises: These files are necessary for participants to complete a number of exercises listed in the man
...
Lancet Infect Dis 2020 Published Online May 5, 2020 https://doi.org/10.1016/ S1473-3099(20)30254-1
The major neglected tropical diseases, Taenia solium taeniosis/cysticercosis and schistosomiasis caused by Schistosoma mansoni or S. haematobium are presumed to be widely distributed in Africa. Taenia solium taeniosis/ cysticercosis has been reported as an emerging disease in different regions of Af
...
Infection 2023 Oct;51(5):1399-1406. doi: 10.1007/s15010-023-01999-9. Epub 2023 Feb 20.
The results indicate a significantly higher rate of infections with S. mansoni in street children compared with orphans. This might be explained by the lack of access to adequate sanitation for street children
...
2nd edition
This document provides up-to-date guidance on laboratory studies as well as smallscale (semi-field) and large-scale field trials to assess the efficacy and determine field application rates of new molluscicide products for control of schistosomiasis.
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher
...
